Benzodiazipines
Diazepam poisoning is treated by:
| A | Flumazenil | |
| B |
Hemofiltration |
|
| C | Charcoal | |
| D |
Resins |
Diazepam poisoning is treated by:
| A | Flumazenil | |
| B |
Hemofiltration |
|
| C | Charcoal | |
| D |
Resins |
Flumazenil REF: Harrison’s 17th ed Table e 35-4
See APPENDIX-42 for list of “Antidotes”
“Specific antidote for benzodiazepine poisoning is flumazenil”
Benzodiazepine antagonist ?
| A |
Flumazenil |
|
| B |
Naloxone |
|
| C | Furazolidone | |
| D |
Naltrexone |
Flumazenil [Ref. K.D.T. 6thIe p399-400 5th/e p 362]
- Benzodiazepine acts by enhancing presynaptic/postsynaptic inhibition through a specific BZD receptor which is an integral part of the GABA receptor-CI— channel complex.
- Flumazenil is a BZD analogue which has little intrinsic activity, but it competes with BZD agonists as well as inverse agonists for the BZD receptor and reverses their depressant or stimulant effects respectively.
- Flumazenil is the drug of choice for benzodiazepene overdose. About other options:
- Naltrexone –> Opioid antagonist
- Butorphanol –> Agonist/antagonist at opioid receptors
- Pralidoxime –> Cholinesterase reactivator
| A | Lorazepam | |
| B |
Orazepam |
|
| C |
Temazepam |
|
| D |
Diazepam |
Diazepam generates active metabolites, has slow elimination and tends to accumulate with regular use.
Lorazepam, Oxazepam and Temazepam do not produce active metabolites and are relatively safer in elderly patients and in those with liver disease.
These agents should be used in preference to diazepam.
Ref: Essentials of Pharmacology By K D Tripathi, 5th Edtion, Page 364.
Shortest acting benzodiazepine is‑
| A |
Flurazepam |
|
| B |
Alprazolam |
|
| C |
Triazolam |
|
| D |
Diazepam |
Ans. is ‘c’ i.e., Triazolam
o Midazolam (slightly shorter acting than triazolam) and triazolam are shortest acting BZDs.
Benzodiazepine without anticonvulsant property is‑
| A |
Nitrazepam |
|
| B |
Diazepam |
|
| C |
Clonazepam |
|
| D |
Temazepam |
Ans. is ‘d’ i.e., Temazepam
BZDs with significant anticonvulsant property are diazepam, clonazepam, nitrazepam, lorazepam and flurazepam.
Antagonist of Benzodiazepine is ‑
| A |
Nalorphine |
|
| B |
Carbamazepine |
|
| C |
Naloxone |
|
| D |
Flumazenil |
Ans. is ‘d’ i.e., Flumazenil
o Flumazenil is a benzodiazepene analogue which competes with BZD agonists as well as inverse agonists for the BZD receptor and reverses their depressant or stimulant effects respectively.
o It also antagonizes the action of Zolpidem, Zopiclone and Zopeplon as these drugs also act on BZD site.
| A | Diazepam inverse agonist | |
| B |
Diazepam antagonist |
|
| C |
Opioid antagonist |
|
| D |
Opioid inverse agonist |
Ans. is ‘b’ i.e., Diazepam antagonist
A 6 yr. old child with acute onset of fever of 104° F developed febrile seizures and was treated. To avoid future recurrence of seizure attacks what should be given –
| A |
Paracetamol 400 mg + Phenobarbitone daily |
|
| B |
Oral Diazepan 6 hourly |
|
| C |
Paracetamol 400 mg 6 hourly |
|
| D |
I.V. diazepam infusion over 12 hrs |
Ans. is ‘b’ i.e., Oral Diazepan 6 hrly
An anxiolytic benzodiazepine which is also antidepressant :
September 2007
| A | Lorazepam | |
| B |
Oxazepam |
|
| C |
Alprazolam |
|
| D |
Chlordiazepoxid |
Ans. C: Alprazolam
Alprazolam is approved for the short-term treatment of panic disorder, with or without agoraphobia. Alprazolam is very effective in the short-term symptomatic relief of moderate to severe anxiety, essential tremor, and panic attacks.
Alprazolam is indicated for the management of anxiety disorders or the short-term relief of symptoms of anxiety. Alprazolam is recommended for the short-term treatment of severe acute anxiety.
Alprazolam is sometimes prescribed for anxiety with associated depression.
The antidepressant effects of alprazolam may be due to its effects on beta-adrenergic receptors. Other benzodiazepines are not known to have antidepressant activity.
March 2010
| A | Protamine | |
| B |
Flumazenil |
|
| C |
Coumarin |
|
| D |
Midazolam |
Ans. B: Flumazenil
Decontamination
– Gastric lavage is not recommended but may be considered if the presence of a lethal co-ingestant is suspected and the patient presents within 1 hour of ingestion.
– Single-dose activated charcoal is recommended for GI decontamination in patients with protected airway who present within 4 hours of ingestion.
- Respiratory depression may be treated with assisted ventilation.
- Flumazenil
– Flumazenil is a competitive BZD receptor antagonist and should be used cautiously because it has potential to precipitate BZD withdrawal in chronic users, resulting in seizures.
– Flumazenil administration is contraindicated in mixed overdoses (e.g., TCAs) because BZD reversal can precipitate seizures and cardiac arrhythmias.
– Ideal indication for flumazenil use is isolated BZD overdose, particularly if overdose is iatrogenic in nature.
Antidote for benzodiazepine poisoning:
FMGE 10, 13; NEET 14
| A | Naloxone | |
| B |
Atropine |
|
| C |
Flumazenil |
|
| D |
N-acetyl-cysteine |
Ans. Flumazenil
IV diazepam has which of the following effect which is not seen by other routes ‑
| A |
Analgesia |
|
| B |
Sedation |
|
| C |
Hypotension |
|
| D |
Coronary dilatation |
Ans. is ‘d’ i.e., Coronary dilatation
Mechanism of action of benzodiazepines (BZDs)
- Benzodiazepines act preferentially on midbrain ascending reticular formation (which maintains wakefulness) and on limbic system (thought and mental function).
- Muscle relaxation is produced by action on medulla.
- Ataxia is due to action on cerebellum.
- BZDs acts on GABAA receptors.
- GABA,,, receptor has 5 subunits a / p, p, a / y.
- GABA binding site is on p. subunit, while BZDs binding site is on a / y subunit.
- BZDs receptor increase the conductance of Cl- channel.
- BZDs do not themselves increase Cl- conductance, i.e. they have only GABA facilitatory but no GABA mimetic action. (Barbiturates have both GABA facilitatory and GABA mimetic actions).
Effect on CNS
- In contrast to barbiturates, BZDs are not general depressant, but exert relatively selective anxiolytic, hypnotic, muscle relaxant and anticonvulsant effects.
- The antianxiety action of BZDs is not dependent on their sedative property —› with chronic administration relief of anxiety is maintained, but drowsiness wanes off due to development of tolerance.
- Stage 2 sleep is increased, while REM, Stage 3 & 4 sleep are decreased.
- Nitrazepam is the only benzodiazepine, which increases REM sleep.
- Clonazepan and diazepam have more marked muscle relaxant property.
- Clonazepam, diazepam, nitrazepam and flurazepam have more prominent anticonvulsant activity than other BZDs.
- Diazepam (but not other BZDs) has analgesic action.
- Diazepam produces short lasting coronary dilatation on i.v. injection.
- Diazepam decreases nocturnal gastric secretion and prevents stress ulcers.
| A | Phenobarbitone | |
| B |
Flumazenil |
|
| C |
Beta carboline |
|
| D |
Gabapentin |
Ans. is `c’ i.e., Beta carboline
Antidote true is all except‑
| A |
Deferoxamine – Iron |
|
| B |
Flumazenil – BZDs |
|
| C |
Dimercaprol – Arsenic |
|
| D |
Naloxone – Datura |
Ans. is i.e., Naloxone-Datura
The antidote for datura poisoning is physostigmine (not naloxone). Naloxone is an opioid antagonist medication used to block or reverse the effects of opioid drugs.
Deferoxamine is the antidote for iron poisoning, flumazenil is the antidote for BZDs poisoning and Dimercaprol is used to treat arsenic, gold, or mercury poisoning. It is also used together with another medicine called edetate disodium (EDTA) to treat lead poisoning.
Midazolam causes all except:
| A | Anterograde amnesia | |
| B |
Retrograde amnesia |
|
| C |
Causes tachyphylaxis during high dose infusions |
|
| D |
Decreased cardiovascular effects as compared to propofol |
Ans. b. Retrograde amnesia
At the time of peak concentration in plasma, hypnotic doses of benzodiazepines (midazolam) can be expected to cause varying degrees of lightheadedness, lassitude, increased reaction time, motor incoordination, impairment of mental and motor functions, confusion, and anterograde amnesia.”
Midazolam:
- It causes anterograde amnesiaQ
- Tolerance and tachyphylaxis may occur, particularly with longer-term infusionsQ(Shafer A. Complications of sedation with midazolam in the intensive care unit and a comparison with other sedative regimens. Crit Care Med. 1998;26(5): 947-56)
- Benzodiazepine withdrawal syndrome has also been associated with high dose/ long-term midazolam infusionsQ
- Compared with propofol infusions, midazolam infusions have been associated with a decreased occurrence of hypotension° but a more variable time course for recovery of function after the cessation of the infusion.
Shortest acting Benzodiazepine ‑
| A |
Diazepam |
|
| B | Midazolam | |
| C | Alprazolam | |
| D |
Chlordiazepoxide |
Ans. is ‘b’ i.e., Midazolam
- Ajay Yadav 4th/e p. 85] o Midazolam is the shortest acting benzodiazipine.
- It is 3 times more potent than diazepam.
- Midazolam is now very commonly used BZD in intraoperative period.
- Advantages of midazolam over diazepam are :
- Water based preparation, so injection is painless.
- Elimination half life is 2-3 hours, so can be safely used for day care procedures.
- Reversal with flumezanil is complete (no resedation).
- Disadvantages are that decrease in BP and peripheral vascularresistance, respiratory depression and incidence of apnea are higher and more profound than diazepam
| A |
Flumazenil |
|
| B |
Naloxone |
|
| C |
Naltrexone |
|
| D |
Dimercaprol |
Ans. is ‘a’ i.e., Flumazenil
Benzodiazepine without anticonvulsant property is-
| A |
Nitrazepam |
|
| B |
Diazepam |
|
| C |
Clonazepam |
|
| D |
Temazepam |
Ans. D. i.e., Temazepam
- BZD’s with significant anticonvulsant properties are diazepam, clonazepam, nitrazepam, lorazepam, and flurazepam.
Shortest acting benzodiazepine is
| A |
Flurazepam |
|
| B |
Alprazolam |
|
| C |
Triazolam |
|
| D |
Diazepam |
Ans. is ‘c’ i.e., Triazolam

